ArticleJournal of molecular cell biology2022

Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way.

Otávio Augusto Chaves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.